Stroke Imaging Research Road Map

Neuroimaging Clinics of North America

Volumn 21, Issue 2, 2011, Pages 239-245

  Leiva Salinas, Carlos ^a,b   Hom, Jason ^c   Warach, Steven ^d   Wintermark, Max ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

CT; DWI; MR imaging; Perfusion; Stroke; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN DISEASE; BRAIN INFARCTION SIZE; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; ISCHEMIC PENUMBRA; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SCINTIGRAPHY; STROKE; STROKE IMAGING REPOSITORY CONSORTIUM;

BIOMEDICAL RESEARCH; CEREBRAL ANGIOGRAPHY; HUMANS; IMAGE ENHANCEMENT; PERFUSION IMAGING; STROKE; UNITED STATES;

EID: 79957814843     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2011.01.009     Document Type: Review

References (21)

1. Bambauer K.Z., Johnston S.C., Bambauer D.E., et al. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol 2006, 63(5):661-664.
2. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359(13):1317-1329.
3. Albers G.W., Thijs V.N., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006, 60(5):508-517.
4. Furlan A.J., Eyding D., Albers G.W., et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37(5):1227-1231.
5. Hacke W., Albers G., Al-Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36(1):66-73.
6. Schellinger P.D., Warach S. Therapeutic time window of thrombolytic therapy following stroke. Curr Atheroscler Rep 2004, 6(4):288-294.
7. Davis S.M., Donnan G.A., Parsons M.W., et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008, 7(4):299-309.
8. Hacke W., Furlan A.J., Al-Rawi Y., et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009, 8(2):141-150.
9. Leiva-Salinas C., Wintermark M. The future of stroke imaging: what we need and how to get to it. AJNR Am J Neuroradiol 2010, 41(Suppl 1):S152-S153.
10. Provenzale J.M., Wintermark M. Optimization of perfusion imaging for acute cerebral ischemia: review of recent clinical trials and recommendations for future studies. AJR Am J Roentgenol 2008, 191(4):1263-1270.
11. Stroke Imaging Repository home Available at:, Accessed September 27, 2010. https://stir.ninds.nih.gov/html/index.html.
12. Wintermark M., Albers G.W., Alexandrov A.V., et al. Acute stroke imaging research roadmap. AJNR Am J Neuroradiol 2008, 29(5). e23-e30.
13. Ali M., Bath P.M., Curram J., et al. The virtual international stroke trials archive. Stroke 2007, 38(6):1905-1910.
14. Virtual International Stroke Trials Archive home Available at:, Accessed September 27, 2010. http://www.vista.gla.ac.uk/.
15. M.R Stroke home Available at:, Accessed September 27, 2010. http://www.mrstroke.com/.
16. Stroke Imaging Repository charter Available at:, Accessed September 27, 2010. https://stir.ninds.nih.gov/html/charter.html.
17. Stroke Imaging Repository projects Available at:, Accessed September 27, 2010. https://stir.ninds.nih.gov/html/projects.html.
18. Wu O., Christensen S., Hjort N., et al. Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI. Brain 2006, 129(Pt 9):2384-2393.
19. Wu O., Koroshetz W.J., Ostergaard L., et al. Predicting tissue outcome in acute human cerebral ischemia using combined diffusion- and perfusion-weighted MR imaging. Stroke 2001, 32(4):933-942.
20. Ostergaard L., Sorensen A.G., Chesler D.A., et al. Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke. Stroke 2000, 31(5):1097-1103.
21. Ay H., Arsava E.M., Vangel M., et al. Interexaminer difference in infarct volume measurements on MRI: a source of variance in stroke research. Stroke 2008, 39(4):1171-1176.